Citrus Sinensis ID: 007629

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-----
MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREVTAVILHYCVHADIFL
cccccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEcccccccccEEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHHccccccCECccccccccccccccEEEEEEccccHHHHHHcccccccHHHHHHHHHHHHHHHccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHHHcccHHHHHHHHccccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcHHHHHHHHccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCEccccccccHHHHHHHHHHcccccccc
*****TL**GVRRW************************************************TIVEDFDFSGLKLIRVPKRIQFPIAP************LETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAH**************************************************************************************KCVGVKDRTDREVTAVILHYCVHADIFL
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MGGSSTLVDGVRRWFQRHSFTNNSNNNNNNNNNNFDSNNKKSNNINTSSSSSSHEGQHLQQLTIVEDFDFSGLKLIRVPKRIQFPIAPTPATMDPHKKSALETEFFTEYGEASRYQIQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPSTESISRIRNEKARRYLGSMRKKQPVPFSHKFPNADPLALHLLERLLAFDPKDRPTAEEALADPYFHGLANVDREPSTQPISKLEFEFERRKLAKDDVREMIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASLPRERVPAPKDENAGQNNDYGRTADSVAATLQSPPTENANTEEQNGINRPNCSARSLLKSASISASKCVGVKDRTDREVTAVILHYCVHADIFL

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Mitogen-activated protein kinase 9 confidentQ9LV37
Mitogen-activated protein kinase 12 May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters.confidentQ5Z9J0
Mitogen-activated protein kinase 17 probableQ6L5F7

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
2.-.-.-Transferases.probable
2.7.-.-Transferring phosphorous-containing groups.probable
2.7.11.-Protein-serine/threonine kinases.probable
2.7.11.24Mitogen-activated protein kinase.probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3RP9, chain A
Confidence level:very confident
Coverage over the Query: 111-454
View the alignment between query and template
View the model in PyMOL
Template: 2XS0, chain A
Confidence level:confident
Coverage over the Query: 101-263,282-451
View the alignment between query and template
View the model in PyMOL